Considering that TauAB is a C-terminal antibody (epitope at amino acids 425–441), it would be expected that the high levels of MTBR peptides in the SI fraction of AD would be accompanied by a corresponding high abundance of C-terminal non-phosphorylated tau peptides. The gene discussed is MAPT; the disease is Alzheimer disease.